californybit
|
|
December 29, 2017, 06:57:22 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work.
|
|
|
|
MkrKing
Member
Offline
Activity: 322
Merit: 12
|
|
December 29, 2017, 07:17:27 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work. Well, the platform can reach such a number of available neural networks with the help of individual programmers, but the work carried out by the developers of the platform won’t be visible. Absence of new features, that’s why I don’t see the point of releasing the beta version that fast.
|
|
|
|
californybit
|
|
December 29, 2017, 07:29:31 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work. Well, the platform can reach such a number of available neural networks with the help of individual programmers, but the work carried out by the developers of the platform won’t be visible. Absence of new features, that’s why I don’t see the point of releasing the beta version that fast. Oh, that’s what you were talking about. There will be an additional SkyTherapist module launched in the beta version, it will be able to create treatment protocols for various diseases.
|
|
|
|
MkrKing
Member
Offline
Activity: 322
Merit: 12
|
|
December 29, 2017, 07:41:23 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work. Well, the platform can reach such a number of available neural networks with the help of individual programmers, but the work carried out by the developers of the platform won’t be visible. Absence of new features, that’s why I don’t see the point of releasing the beta version that fast. Oh, that’s what you were talking about. There will be an additional SkyTherapist module launched in the beta version, it will be able to create treatment protocols for various diseases. This sounds more interesting. And how many diseases will the AI of this module “be aware of”?
|
|
|
|
californybit
|
|
December 29, 2017, 07:58:06 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work. Well, the platform can reach such a number of available neural networks with the help of individual programmers, but the work carried out by the developers of the platform won’t be visible. Absence of new features, that’s why I don’t see the point of releasing the beta version that fast. Oh, that’s what you were talking about. There will be an additional SkyTherapist module launched in the beta version, it will be able to create treatment protocols for various diseases. This sounds more interesting. And how many diseases will the AI of this module “be aware of”? If you believe the statements of developers, the SkyTherapist will be aware of more than 200 of the most common diseases (infectious, chronic, etc.) and the 30 most common oncologic diseases.
|
|
|
|
askon
|
|
December 29, 2017, 08:11:39 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work. Well, the platform can reach such a number of available neural networks with the help of individual programmers, but the work carried out by the developers of the platform won’t be visible. Absence of new features, that’s why I don’t see the point of releasing the beta version that fast. Oh, that’s what you were talking about. There will be an additional SkyTherapist module launched in the beta version, it will be able to create treatment protocols for various diseases. This sounds more interesting. And how many diseases will the AI of this module “be aware of”? If you believe the statements of developers, the SkyTherapist will be aware of more than 200 of the most common diseases (infectious, chronic, etc.) and the 30 most common oncologic diseases. The fact that AI can prescribe the treatment for patients itself is just a huge step forward for the entire medicine science!!! And does anyone know how will the process of operation of SkyTherapist be carried out?
|
|
|
|
nothappend
|
|
December 29, 2017, 09:29:06 AM |
|
Hi there, comrades! What are the results of pre-ICO? Is the soft cap already reached?
|
|
|
|
MadduckUK
|
|
December 29, 2017, 09:51:13 AM |
|
Hi there, comrades! What are the results of pre-ICO? Is the soft cap already reached?
Yes, the soft cap has long been reached for sure, it can’t but rejoice!
|
|
|
|
sarakeyyy
Member
Offline
Activity: 99
Merit: 10
|
|
December 29, 2017, 10:09:54 AM |
|
I was confused be the fact that the period of time between the release of alpha and beta versions of the platform will be very small. Does it make any sense to release the beta so early, if the there won’t be any special changes? They’d better develop it a little, and release a more modified version of Skychain later.
Why did you decide that there will be no changes? If 30 ANN will be available in alpha version, their number will increase more than three times in the beta version. In my opinion, this is more than a good indicator of work. Well, the platform can reach such a number of available neural networks with the help of individual programmers, but the work carried out by the developers of the platform won’t be visible. Absence of new features, that’s why I don’t see the point of releasing the beta version that fast. Oh, that’s what you were talking about. There will be an additional SkyTherapist module launched in the beta version, it will be able to create treatment protocols for various diseases. This sounds more interesting. And how many diseases will the AI of this module “be aware of”? If you believe the statements of developers, the SkyTherapist will be aware of more than 200 of the most common diseases (infectious, chronic, etc.) and the 30 most common oncologic diseases. If this is true, then I want to praise this project, because it can subvert our health care industry
|
|
|
|
Mat24
Member
Offline
Activity: 238
Merit: 10
|
|
December 29, 2017, 12:23:52 PM |
|
What happens if the hard cap level is reached during pre-ICO?
|
|
|
|
Gamelander
|
|
December 29, 2017, 12:31:17 PM |
|
What happens if the hard cap level is reached during pre-ICO?
Hello. Nothing special will happen, pre-ICO will just be over ahead of schedule and preparations for the ICO will be started.
|
|
|
|
yeyz600
Member
Offline
Activity: 196
Merit: 41
|
|
December 29, 2017, 12:53:25 PM |
|
Skychain this coin project, ICO, seems to have a big appetite. Do you really need so much money to complete your roadmap at once?
|
|
|
|
polonium84
|
|
December 29, 2017, 04:25:03 PM |
|
Good afternoon. I’ve read that you plan to launch an alpha version of your platform in June 2018. How many neural networks will be available for early users of the system?
|
|
|
|
rdizza
|
|
December 29, 2017, 05:23:13 PM |
|
Greetings to everybody. Can anybody explain me how the platform will be able to determine people’s health problems basing on images and graphical studies?
|
|
|
|
waitsummer
Member
Offline
Activity: 406
Merit: 10
|
|
December 29, 2017, 06:29:01 PM |
|
How long will it take the service to determine that the patient has an early stage cancer?
|
|
|
|
gazman
Member
Offline
Activity: 238
Merit: 10
|
|
December 29, 2017, 07:30:03 PM |
|
I’ve seen the info that the SkyTherapist would offer several treatment options for one disease at once. And what are the differences between these options?
|
|
|
|
defender77
|
|
December 30, 2017, 10:43:19 AM |
|
Will there be only 200 diseases in a final version of the platform? Are you kidding?? It’s ridiculous. The platform will have small demand in such a case. You’d better think over scaling and work with large amount of diseases and you’ll benefit.
|
|
|
|
Mops
|
|
December 30, 2017, 10:55:40 AM |
|
Will there be only 200 diseases in a final version of the platform? Are you kidding?? It’s ridiculous. The platform will have small demand in such a case. You’d better think over scaling and work with large amount of diseases and you’ll benefit.
The platform will support 200 diseases at the alpha test stage; the full version will support more than 1000 various diseases and prescribe out-patient treatment.
|
|
|
|
defender77
|
|
December 30, 2017, 11:08:51 AM |
|
Will there be only 200 diseases in a final version of the platform? Are you kidding?? It’s ridiculous. The platform will have small demand in such a case. You’d better think over scaling and work with large amount of diseases and you’ll benefit.
The platform will support 200 diseases at the alpha test stage; the full version will support more than 1000 various diseases and prescribe out-patient treatment. A full version of the platform? When will it be launched?
|
|
|
|
Mops
|
|
December 30, 2017, 11:18:47 AM |
|
Will there be only 200 diseases in a final version of the platform? Are you kidding?? It’s ridiculous. The platform will have small demand in such a case. You’d better think over scaling and work with large amount of diseases and you’ll benefit.
The platform will support 200 diseases at the alpha test stage; the full version will support more than 1000 various diseases and prescribe out-patient treatment. A full version of the platform? When will it be launched? It’s planned to launch it in June, 2019. The dates can be pushed back or forward a little.
|
|
|
|
|